Truvian Sciences uses 7 drops of blood to produce lab accurate results in 20 minutes for a full suite of health tests but it has competitors both at home and abroad as it seeks to take on traditional lab testing providers like Quest Diagnostics and LabCorp.
San Diego, California-based Genalyte has spent 10 years developing its lab-on-a-chip technology. Now it’s ready, to try it out on J.P. Morgan investors, quite literally.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
The point-of-care transformation is well underway as healthcare and tech companies dive into a market now worth over $18 billion a year.
With $36 million in new funding, San Diego-based Genalyte is carrying the torch for simplified diagnostics, developing a finger-prick blood test that can deliver results in just minutes.
Here's a look at a company that could seriously be in the running for Theranos' biggest competitor.